- Home
- ARBE vs LXRX Comparison
ARBE vs LXRX Comparison
Compare ARBE & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- LXRX
- Stock Information
- Founded
- ARBE 2015
- LXRX 1995
- Country
- ARBE Israel
- LXRX United States
- Employees
- ARBE N/A
- LXRX N/A
- Industry
- ARBE EDP Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- ARBE Technology
- LXRX Health Care
- Exchange
- ARBE Nasdaq
- LXRX Nasdaq
- Market Cap
- ARBE 275.1M
- LXRX 283.7M
- IPO Year
- ARBE N/A
- LXRX 2000
- Fundamental
- Price
- ARBE $2.24
- LXRX $0.71
- Analyst Decision
- ARBE Strong Buy
- LXRX Buy
- Analyst Count
- ARBE 2
- LXRX 2
- Target Price
- ARBE $3.00
- LXRX $4.00
- AVG Volume (30 Days)
- ARBE 7.6M
- LXRX 4.1M
- Earning Date
- ARBE 03-05-2025
- LXRX 03-10-2025
- Dividend Yield
- ARBE N/A
- LXRX N/A
- EPS Growth
- ARBE N/A
- LXRX N/A
- EPS
- ARBE N/A
- LXRX N/A
- Revenue
- ARBE $1,016,000.00
- LXRX $5,229,000.00
- Revenue This Year
- ARBE $1.56
- LXRX $842.94
- Revenue Next Year
- ARBE $395.31
- LXRX $19.76
- P/E Ratio
- ARBE N/A
- LXRX N/A
- Revenue Growth
- ARBE N/A
- LXRX 886.60
- 52 Week Low
- ARBE $1.40
- LXRX $0.62
- 52 Week High
- ARBE $5.09
- LXRX $2.83
- Technical
- Relative Strength Index (RSI)
- ARBE 41.73
- LXRX 43.33
- Support Level
- ARBE $2.62
- LXRX $0.66
- Resistance Level
- ARBE $2.69
- LXRX $0.97
- Average True Range (ATR)
- ARBE 0.25
- LXRX 0.07
- MACD
- ARBE -0.06
- LXRX -0.00
- Stochastic Oscillator
- ARBE 1.03
- LXRX 16.13
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.